Kevin Doe

Kevin Doe's articles

Roots-8c1582bb

PRE-STERILIZED / READY-TO-USE PRIMARY PACKAGING MARKET – GAINING POPULARITY IN THE PHARMACEUTICAL INDUSTRY AND THE RISING FUTURE POTENTIAL

Primary packaging, such as vials, syringes, and cartridges, and their affiliated closures, play a vital role in ensuring the stability, and sterility, and thereby, the overall quality, efficacy and safety of a drug product. Moreover, the packaging bears the product label, which provides information related to the drug and, in certain cases, dosing instructions.[1] Pharmaceutical […]
Roots-9ece8e30

The light activated therapies market is anticipated to grow

Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products   London   Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic Therapies, […]

COMPANY COMPETITIVENESS ANALYSIS – ATTAINING A COMPETITIVE EDGE OVER OTHERS BY EXPLORING EXISTING POTENTIAL

Industry stakeholders are steadily expanding their existing capabilities in order to enhance their respective product portfolios and maintain a competitive edge in this steadily evolving market. The companies considered in this analysis have been divided into relevant peer groups (based on company size) and scored on the basis of various parameters, such as types of […]

The light activated therapies market is anticipated to grow at an annualized rate of 27.7% till 2030, claims Roots Analysis

  Light activated therapies are considered to be a transformative approach owing to their capability to eradicate diseased cells from the body with minimal side effects; presenting lucrative opportunities for players engaged in the development of such products   London   Roots Analysis has announced the addition of “Light Activated Therapies Market: Focus on Photodynamic […]
download-ecbc3613

The vascular disrupting agents market is projected to be worth USD 2 billion by 2030, claims Roots Analysis

  Vascular disrupting agents (VDAs) are the novel oncology drugs being developed to more specifically combat complex, life threatening cancer indications   Roots Analysis is pleased to announce the publication of its recent study, titled, “Vascular Disrupting Agents Market, 2021-2030”   The report features an extensive study of the current market landscape, offering an informed […]
download-a37de2af

The soft tissue sarcoma market is projected to be worth over USD 420 million in 2030, claims Roots Analysis

Recent advances in molecular biology have enabled researchers to develop a better understanding of the rare soft tissue sarcomas; as a result, a number of viable biological targets have been identified and are being investigated for therapeutic relevance   Roots Analysis has announced the addition of “Soft Tissue Sarcoma: Focus on Angiosarcoma, Chondrosarcoma, and Liposarcoma […]
Roots Analysis Full Logo (1)-9309a1b0

The TIL-based therapies market is projected to grow at an annualized rate of ~20.3%, till 2030, claims Roots Analysis

Driven by the potential to confer sustained therapeutic effects and thereby facilitate prolonged periods of remission, TIL-based therapies have received significant financial support, and promising leads are poised to soon achieve blockbuster status   Roots Analysis has announced the addition of “TIL-based Therapies Market, 2021-2030” report to its list of offerings.   The report features […]

The prefilled syringe fill / finish services market is estimated to is estimated to reach close to U

The numerous benefits offered by prefilled syringes, coupled to the growing self-medication trend, have led to the approval of a number of drugs in combination with such devices, resulting in an increase in need to outsource fill / finish operations Roots Analysis is pleased to announce the publication of its recent study, titled, “Prefilled Syringe […]

The fragment-based drug discovery market is estimated to be worth around USD 1.6 billion by 2030, pr

Screening small molecule fragments has made it possible to identify pharmacological leads against otherwise hard to target hotspots on biomolecules, such as allosteric sites, rendering this approach a valuable alternative method of drug discovery Roots Analysis is pleased to announce the publication of its recent study, titled, “Fragment-based Drug Discovery Market: Library and Service Providers, 2020-2030.” The […]

The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030.

Outsourcing has become a popular trend among ophthalmic drug developers, allowing them to leverage the expertise / larger production capacities of CMOs / CDMOs and achieve significant cost and time related advantages Roots Analysis is pleased to announce the publication of its recent study, titled, “Ophthalmic Drugs Contract Manufacturing Market: Focus on Active Pharmaceutical Ingredients […]

The patient recruitment and retention services market is estimated to be worth USD 5.3 billion in 20

A steadily increasing demand for participants in clinical research studies, coupled to the complexities associated with patient enrolment, have prompted drug / therapy developers to outsource this process to specialty service providers  Roots Analysis  is pleased to announce the publication of its recent study, titled, “Patient Recruitment and Retention Services Marker, 2019-2030.” The report offers […]

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030, growing at

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings. Although biopharmaceuticals offer significant […]

The contract manufacturing market for Pharmaceuticals in China is estimated to be worth USD 13 billi

Owing to reasons, such as a booming economy and availability of skilled labor, outsourcing to Asian CMOs, primarily in China, is considered an attractive business model to pharmaceutical developers / sponsors, across the world Roots Analysis is pleased to announce the publication of its recent study, titled, “China Pharmaceutical Contract Manufacturing Services Market, 2020-2030.” The […]

The Companion Diagnostics Development Services Market is estimated to be worth over USD 800 million

In the last couple of years, a record number of personalized therapeutic products were approved in the US, establishing an urgent need for companion diagnostics and causing many drug developers to actively seek external support and expertise Roots Analysis is pleased to announce the publication of its recent study, titled, “Companion Diagnostics Development Services Market, 2020-2030” The […]

The antibody contract manufacturing market is projected to reach USD 17 billion by 2030

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings. Although biopharmaceuticals offer significant profit […]

Oligonucleotide Synthesis, Modification and Purification Services Market

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030” […]

Over 300 CROs presently claim to possess the necessary capabilities to offer a wide range of preclin

Given the complex R&D protocols and the increasing demand for clinical evidence of therapeutic benefit, there seems to be a lucrative opportunity for contract research providers engaged in the medical devices’ domain. In fact, since 2000, 150 new CROs have been established that offer a variety of cost-efficient services and solutions to medical device developers. […]

In vitro ADME testing services market is likely to be worth USD 2.2 billion by 2030, predicts Roots

With increasing cases of drug failure, due to problems associated with pharmacokinetic profiles of candidate therapies, absorption, distribution, metabolism and excretion (ADME) properties and inherent toxicity, industry players are actively looking for more advanced solutions. Roots Analysis is pleased to announce the publication of its recent study, titled, “In Vitro ADME Testing Services Market, 2019-2030” The […]

The antibody contract manufacturing market is growing at an annualized rate of 12%, claims Roots An

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings. Although biopharmaceuticals offer significant […]

The study features in-depth analyses, highlighting the capabilities of a diverse set of biopharmaceu

To order this detailed 780+ page report, please visit this link Key Inclusions A detailed review of the overall landscape of the biopharmaceutical contract manufacturing market, featuring an elaborate list of active CMOs, along with information on a number of relevant parameters, such as year of establishment, company size, location of headquarters, types of biologics manufactured […]

The bispecific antibody therapeutics market is estimated to be worth USD 6.9 billion in 2030

With over 100 therapeutic monoclonal antibodies and antibody-based products in the market, the demand for developing and manufacturing of such products is anticipated to increase beyond the capabilities of innovator companies alone Roots Analysis has announced the addition of the “Antibody Contract Manufacturing Market, 2020-2030” report to its list of offerings. Although biopharmaceuticals offer significant […]

Medical Device Batteries: Focus on Implants and Wearable Medical Devices by Roots Analysis

An exponential increase in development efforts related to wearable medical devices and implants, has fueled a corresponding rise in demand for safe, compact, light-weight and high energy density batteries with longer life span   Roots Analysis has announced the addition of “Medical Device Batteries: Focus on Implants and Wearable Medical Devices – Market Distribution by […]

Novel Vaccine Delivery Devices Market, 2019-2030 by Roots Analysis

Owning to a variety of relevant reasons, which include trypanophobia and dependence on the cold chain, there is an evident demand for innovative and user-friendly vaccine delivery systems that are also safe and efficient Roots Analysis is pleased to announce the publication of its recent study, titled, “Novel Vaccine Delivery Devices Market, 2019-2030”. The report […]

Next Generation Immune Checkpoint Inhibitors and Stimulators Market by Roots Analysis

Therapies targeting novel inhibitory and stimulatory immune checkpoints have been shown to possess substantial therapeutic potential, both as monotherapies and in combination with other interventions, across multiple disease interventions Roots Analysis is pleased to announce the publication of its recent study, titled, “Next Generation Immune Checkpoint Inhibitors and Stimulators Market, 2020-2030.” The report features an […]

Manufacturing Market Continuous by Roots Analysis

Recent advances in the manufacturing technologies have prompted pharmaceutical companies to consider shifting from the traditional multi-step, batch manufacturing processes to faster, and relatively more efficient continuous manufacturing Roots Analysis is pleased to announce the publication of its recent study, titled, “Manufacturing Market Continuous (Small Molecules and Biologics), 2020 – 2030.” The report features an […]

Nearly 300 non-invasive diagnostic tests, Claims Roots Analysis

Given the invasive and cost-intensive nature of tissue biopsies, there is a significant unmet need for safer and more patient-friendly cancer diagnostics that are capable of offering highly accurate, and actionable insights related to the disease.   To order this 350+ page report, which features 150+ figures and 200+ tables, please visit this – https://www.rootsanalysis.com/reports/view_document/liquid-biopsy-and-nicd-market/279.html The […]

Interestingly, the majority (>55%) of such service providers firms are based in Europe, claims Roots

Repurposing of marketed / shelved / pipeline candidates for the treatment of diseases (different from original target indications) has emerged as a viable business strategy. The rising popularity of this approach can further be attributed to various benefits, such as reduced development timelines, decreased investments and relatively higher success rates (considering that the safety profiles […]

The non-invasive cancer diagnostics market is estimated to be worth around USD 20.1 billion by 2030.

  Liquid biopsies have emerged as a versatile diagnostic solution, especially for cases when conventional (invasive) diagnostic tests are inconclusive or when the clinical condition is related to an organ that is not amenable to biopsy access Roots Analysis is pleased to announce the publication of its recent study, titled, “Liquid Biopsy and Other Non-Invasive Cancer […]

The drug repurposing service providers market, predicts Roots Analysis

  Drug repurposing enables drug developers to optimize on past efforts and expenditure, thereby, offering a viable life cycle management strategy for marketed products and opportunities to re-evaluate failed / shelved drug development programs Roots Analysis is pleased to announce the publication of its recent study, titled, “Drug Repurposing Service Providers Market, 2020-2030.” The report […]

Antibody drug conjugates market is estimated to be worth more than 15 billion in 2030, predicts Root

Report Keywords – Antibody Drug, Conjugates, Roots Analysis, Biotech, Analysis    Antibody drug conjugates (ADCs) represent a transformative approach to modern cancer treatment; over the years, this upcoming class of targeted therapeutic agents has generated significant enthusiasm within the medical science community Roots Analysis is pleased to announce the publication of its recent study, titled, […]

The blood-brain barrier (BBB) penetrating drugs market is estimated to be worth USD 900 million in 2

Advances in biotechnology have enabled the development of versatile in vitro (static and dynamic), in vivo (micro-dialysis), and in situ (brain perfusion) blood–brain barrier models, allowing more effective and safe delivery of drugs across brain capillaries Roots Analysis is pleased to announce the publication of its recent study, titled, “Blood-Brain Barrier (BBB) Market (2nd Edition), […]

The biopharmaceutical contract biomanufacturing market is projected to be worth USD 32.4 billion by

Owing to the complexities associated with the production of biologics, biopharmaceutical developers are likely to continue relying on contract service providers for various aspects of their respective product development programs London Roots Analysis has announced the addition of the “Biopharmaceutical Contract Biomanufacturing Market, (4th Edition), 2020-2030” report to its list of offerings. Given the rising popularity […]

The global, handheld X-ray imaging devices market is projected to be worth USD 2.8 billion by 2030,

Besides portability, handheld X-ray scanners offer a wide range of benefits, including cost savings; in the initial days of the pandemic, such devices were instrumental in increasing diagnostic throughput since they could be easily sterilized   Roots Analysis has announced the addition of “Global Handheld X-Ray Imaging Devices Market by Area of Application (Dental and […]

“Nuclear Medicine and Radiopharmaceutical Manufacturing Market, 2020-2030”

To order this detailed 320+ page report, please visit this – https://www.rootsanalysis.com/reports/nuclear-medicine-and-radiopharmaceuitcals-manufacturing.html Key Inclusions A detailed assessment of the current market landscape with respect to the players (industry and non-industry) involved in manufacturing radiopharmaceuticals. It features information on the year of establishment, company size, purpose of production (fulfilling in-house requirements / for contract services), location of […]

Close to 130 industry and non-industry players, across the globe, claim to have the necessary expert

The production of radiopharmaceuticals as compared to traditional pharmaceuticals is a multifaceted procedure and requires specialized facilities, equipment and operational expertise. Further, owing to its inherent hazardous nature, radiopharmaceuticals have a complex regulatory market authorization process. Consequently, a number of innovator companies have demonstrated a preference for outsourcing radiopharmaceutical manufacturing to contract service providers.   […]

The nuclear medicine and radiopharmaceuticals manufacturing market grow at an annualized rate of ove

Roots Analysis has announced the addition of “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” report to its list of offerings. To order this 320+ page report, which features 45+ figures and 100+ tables, please visit this link Key Market Insights  Close to 130 industry and non-industry players, across the globe, claim to have the necessary expertise […]

Nuclear medicine and radiopharmaceutical manufacturing market is estimated more than USD 6 billion

The recent surge in the demand of radiopharmaceuticals for diagnostic and therapeutic applications, coupled with the introduction of theranostics, has opened up opportunities for companies having capabilities to manufacture nuclear medicine and radiopharmaceuticals Roots Analysis is pleased to announce the publication of its recent study, titled, “Nuclear Medicine and Radiopharmaceuticals Manufacturing Market, 2020-2030” The report […]

‘Biologics Fill / Finish Service Providers, 2019-2030’

To order this detailed 480+ page report, please visit this – https://www.rootsanalysis.com/reports/view_document/biologics-fill–finish-services-market-2019-2030/256.html Key Inclusions A detailed assessment of the current market landscape, including information on drug developer(s), phase of development (marketed, clinical and preclinical / discovery stage) of lead candidates, target immune checkpoints, their respective mechanisms of action (inhibitory or stimulatory), type of therapeutic modality used […]

Login

Welcome to WriteUpCafe Community
Join our community to engage with fellow bloggers and increase the visibility of your blog.
Join WriteUpCafe